<p>Bortezomib is a proteasome inhibitor indicated for:</p>

<ul>
	<li>Treatment of patients with multiple myeloma</li>
	<li>Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy</li>
</ul>